In vitro data from six melanoma cell lines with representative fusion kinases demonstrated different responses to RAF/MEK inhibition based on specific features of translocation, with translocations that yielded a higher expression level being associated with more resistance [61]. Here, MAP2K7 is linked to melanoma.